COMMUNIQUÉS West-GlobeNewswire

Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025
01/07/2025
AURORA, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), a Colorado based company focused on operating in the regulated cannabis markets in the United States, today announced its financial [...]
Dogecoin Cash Inc. (OTCQB: DOGP) Forms Dogecoin Treasury, Inc. to Support Development of Dogecoin-Related Tools and Infrastructure
01/07/2025
Support Development of Dogecoin-Related Tools and Infrastructure MESQUITE, NV, July 01, 2025 (GLOBE NEWSWIRE) -- Mesquite, NV – July 1, 2025 – Dogecoin Cash Inc. (OTCQB: DOGP), a publicly traded company engaged in [...]
Foundation for Sarcoidosis Research Announces Launch of Enhanced Sarcoidosis Data Registry
01/07/2025
CHICAGO, July 01, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to finding a cure for sarcoidosis and improving care for those affected, is [...]
BioNTX Expands 2025 Tech Transfer Showcase to Spotlight Regional Innovation and Collaboration
01/07/2025
DALLAS, July 01, 2025 (GLOBE NEWSWIRE) -- BioNTX , the premier trade organization for biotechnology and healthcare innovation in North Texas, is proud to announce the expansion of its 4th annual Tech Transfer Showcase [...]
VigRX Plus: Exploring the Science and Safety Behind a Popular VigRX Plus Natural Over the Counter Male Enhancement Supplement
01/07/2025
Explore the science, safety, and clinical insights behind VigRX Plus in 2025 — a leading natural male enhancement supplement trusted worldwide. New York City, NY, July 01, 2025 (GLOBE NEWSWIRE) -- In a rapidly evolving [...]
Cellectar Biosciences Announces Pricing of $6 Million Underwritten Public Offering
01/07/2025
FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the [...]
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
01/07/2025
-Trinity Biotech projects it reached Adjusted EBITDA 1 -positive operations during Q2 2025 and expects to be Adjusted EBITDA 1 positive going forward, reflecting continued strong execution on its comprehensive [...]
First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology
01/07/2025
ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the publication of initial [...]
LiveWorld Releases First-Ever AI Brand Reputation Index for Leading OTC Brands
01/07/2025
Study highlights how AI tools like ChatGPT are shaping reputation and consumer perception of leading OTC brands CAMPBELL, Calif. and NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Campbell, California and New York City – [...]
Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic
01/07/2025
-- Milestone expands global reach and reinforces commitment to accessible, first-line infertility solutions -- ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical innovator [...]
Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis
01/07/2025
The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007 in patients with moderate-to-severe atopic dermatitis Topline data expected in the fourth quarter of 2026 SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE [...]
Visory Health Wins Gold at the 2025 Digital Health Awards
01/07/2025
Award-winning health tech company brings prescription savings to over 38,700 pharmacies nationwide ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health , a leading patient-first health tech prescription [...]
Processa Pharmaceuticals Provides Portfolio and Business Update
01/07/2025
Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852 Continue enrolling patients in Phase 2 study of PCS6422 Strengthened balance sheet with $7M capital infusion VERO BEACH, Fla [...]
Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment
01/07/2025
World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across the country THE VILLAGES, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Every [...]
IGM Biosciences Enters into Agreement to Be Acquired by Concentra Biosciences for $1.247 in Cash per Share Plus a Contingent Value Right
01/07/2025
MOUNTAIN VIEW, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company that has focused on developing engineered IgM-based therapeutic antibodies, today announced that it [...]
H.H.C. Group Celebrates 30 Years of Industry Leadership in Healthcare Cost Containment
01/07/2025
ROCKVILLE, Md., July 01, 2025 (GLOBE NEWSWIRE) -- H.H.C. Group (H.H.C.), a leader in reducing healthcare costs by providing high-quality cost containment using claim negotiation, repricing and independent review [...]
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
01/07/2025
MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 years Ongoing investment in in-house [...]
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (“IPF”)
01/07/2025
Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects, limited patient compliance and no impact on survival 2- and 6-week interim safety results [...]
Earth Science Tech, Inc. Qualifies for and Joins New OTCID Tier
01/07/2025
Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring, optimizing, and scaling high-potential operating businesses [...]

Pages